HIV-1-infection Clinical Trials

37 recruiting

HIV-1-infection Trials at a Glance

37 actively recruiting trials for hiv-1-infection are listed on ClinicalTrialsFinder across 6 cities in 29 countries. The largest study group is Phase 2 with 13 trials, with the heaviest enrollment activity in Atlanta, San Francisco, and Johannesburg. Lead sponsors running hiv-1-infection studies include Gilead Sciences, Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, and Massachusetts General Hospital.

Browse hiv-1-infection trials by phase

Treatments under study

About HIV-1-infection Clinical Trials

Looking for clinical trials for HIV-1-infection? There are currently 37 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new HIV-1-infection trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about HIV-1-infection clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 37 trials

Recruiting
Not Applicable

Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV

ObesityHIV-1-infection
University College Dublin80 enrolled1 locationNCT04174755
Recruiting
Early Phase 1

Cannabis Use, Cognition, and the Endocannabinoid System in HIV

HIV-1-infection
University of California, San Diego138 enrolled1 locationNCT04883255
Recruiting
Phase 2

Evaluation of Long-Acting Lenacapavir for the Treatment of HIV-1 in Treatment-experienced Adolescents and Children

HIV-1-infection
Gilead Sciences12 enrolled9 locationsNCT06749054
Recruiting
Phase 1Phase 2

Study of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living With HIV-1, Two to Less Than 12 Years of Age

HIV-1-infection
National Institute of Allergy and Infectious Diseases (NIAID)90 enrolled12 locationsNCT05660980
Recruiting

Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States

HIV-1-infectionPregnancy RelatedBreastfeeding
International Maternal Pediatric Adolescent AIDS Clinical Trials Group1,150 enrolled11 locationsNCT07293559
Recruiting
Phase 4

A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments

HIV-1-infection
Gilead Sciences350 enrolled14 locationsNCT06337032
Recruiting
Phase 2

A Clinical Trial of STP0404 in Adults With HIV-1 Infection

HIV-1-infection
ST Pharm Co., Ltd.36 enrolled13 locationsNCT05869643
Recruiting
Phase 1

Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Newborns Exposed to HIV

HIV-1-infection
Gilead Sciences16 enrolled7 locationsNCT07055451
Recruiting
Phase 1

Study of GS-3242 in Participants With HIV-1; Substudy-05

HIV-1-infection
Gilead Sciences30 enrolled28 locationsNCT07001319
Recruiting
Phase 1Phase 2

Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1

HIV-1-infection
National Institute of Allergy and Infectious Diseases (NIAID)36 enrolled12 locationsNCT06071767
Recruiting
Not Applicable

Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)

DepressionInflammationHIV-1-infection
Florida International University150 enrolled2 locationsNCT05136703
Recruiting
Not Applicable

Acceptance and Commitment Therapy for HIV+ Hazardous Drinkers

HIV-1-infectionAlcohol Drinking
Syracuse University300 enrolled1 locationNCT06648629
Recruiting
Phase 2Phase 3

Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1

HIV-1-infection
Gilead Sciences75 enrolled21 locationsNCT06532656
Recruiting
Phase 3

DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People Living With HIV-1 Infection

HIV-1-infection
ANRS, Emerging Infectious Diseases610 enrolled19 locationsNCT06203132
Recruiting
Phase 2

Improving Coronary Vascular Health in Women

Metabolic DiseaseHIV-1-infectionCoronary Microvascular Dysfunction
Massachusetts General Hospital80 enrolled1 locationNCT06843902
Recruiting
Phase 3

Ndovu RCT: Investing the Optimal Management of Dolutegravir Resistance

HIV-1-infection
University of Nairobi392 enrolled9 locationsNCT06747507
Recruiting

Investigating the Optimal Management of Dolutegravir Resistance

HIV-1-infection
University of Nairobi6,600 enrolled9 locationsNCT06762054
Recruiting
Phase 2

Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV

FrailtyAgingHIV-1-infection+2 more
Massachusetts General Hospital100 enrolled2 locationsNCT06554717
Recruiting

Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US

HypertensionType 2 DiabetesHIV-1-infection+1 more
Duke University150 enrolled2 locationsNCT05129345
Recruiting
Not Applicable

Ending the Epidemic Interventions in the Dental Setting - UH3

HIV-1-infection
Columbia University128 enrolled3 locationsNCT06890988